Even though FDA briefing documents were skeptical, the proverbial dog did not bark at ODAC, where three drugs had a smooth passage. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
